Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Namrata Saroj Sells 35,370 Shares in RSU Tax Withholding

Namrata Saroj, Chief Business Officer of Ocular Therapeutix, Inc., filed a Form 4 on November 9, 2026, disclosing the sale of 35,370 shares of common stock on November 5, 2026, pursuant to a Rule 10b5-1 automatic sale instruction to cover tax withholding obligations tied …

Shwetambri Chauhan | 09 November 2026

Franklin Financial Q3 2026: Net Income Rises to $8.5M

Franklin Financial Services Corporation filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing third-quarter net income of $8,535 thousand and nine-month net income of $21,783 thousand.

Aditi Sarkar | 09 November 2026

Artiva Biotherapeutics Estimates $27M-$35M Wind Down Costs

Artiva Biotherapeutics, Inc. filed a Form 8-K/A amendment on November 9, 2026, providing cost estimates for its previously announced wind-down of AlloNK development and workforce reduction that were unavailable at the time of the original October 27, 2026 filing.

Manish Choudhary | 09 November 2026

American Public Education Q3 2026 Financial Results Released

American Public Education, Inc. filed a Form 8-K with the SEC on November 9, 2026, reporting that it issued a press release covering financial results for the three and nine months ended September 30, 2026.

Aditi Sarkar | 09 November 2026

Inogen Q3 2026: $10.6M Goodwill Impairment Hits Results

Inogen, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the three and nine months ended September 30, 2026, disclosing a net loss of $16.2 million for the quarter and a $10.6 million impairment charge recorded in …

Nitish Kishor | 09 November 2026

Werner Enterprises Q3 2026: Net Income $6.6M on $950.5M Revenue

Werner Enterprises, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting a return to profitability in the third quarter after a loss in the same period a year earlier.

Nitish Kishor | 09 November 2026

Thryv Holdings Files Q3 2026 Report Amid Going-Concern Doubt

Thryv Holdings, Inc. (NASDAQ:THRY) submitted its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing a going-concern warning and ongoing strategic initiatives including a planned divestiture of its print business.

Aditi Sarkar | 09 November 2026

WhiteHawk Therapeutics Q3 2026: $60M Nine-Month Net Loss

WhiteHawk Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting continued operating losses and balance sheet changes following a mid-year private placement.

Anjali Anand | 09 November 2026

Hain Celestial Q1 FY2027: Net Sales Fall to $260.3M

The Hain Celestial Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting net sales of $260,274 thousand and an operating loss of $14,976 thousand for the three …

Aakashdeep | 09 November 2026

National Health Investors Q3 2026: $562.7M Gain Quarter

National Health Investors, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting results for the three and nine months ended that date.

Manish Choudhary | 09 November 2026
Support

Hi! How can we help you today?

Loading…